Sign in
Enrolling by invitationNo phase

Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation

Key facts

Who runs it
Centre Cardiologique du Nord
Where
France2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
600 people, planned
Started
1 Jun 2017
Expected to end
30 Dec 2026
Type of study
Observational, 4 groups
Treatments tested
  • Trancatheter Edge to Edge Repair
  • Mitral Valve Replacement
  • Restrictive Mitral Annuloplastie
  • Restrictive Mitral Annuloplastie/Subvalvular Repair
Record updated
19 May 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Adult
  • Ischemic NoIschemic cardiomyopathy
  • EROA> 0,2 cm2 or Regurgitant Volume > 30 ml (ESC guidelines)
  • EROA ≥ 0.4 cm2 with tethering (ACC/AHA)
  • MR Grade 3/4
  • Eligible for TEE, surgical repair and replacement of mitral valve
  • Coronary artery disease with or without the need for coronary revascularization
  • Average value LVEDD 62 mm LVEF 42%

Who cannot take part

  • Any echocardiographic evidence of structural (chordal or leaflet) mitral-valve disease
  • Pediatric
  • ruptured papillary

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The mechanical intervention is treating secondary mitral regurgitation (SMR) which may be performed using the standard open surgical approach or transcatheter edge to edge repair (TEER). The key question of this study is to establish the difference in left ventricular reverse remodeling after adjustment for death, as assessed by means of the left ventricular end-systolic dimension(LVESD), all-cause and cause-specific (cardiac vs noncardiac) mortality in patients who received the TEER vs the standard surgical procedure for SMR.

The 4 groups in the trial

  • Transcatheter Edge to Edge Repair

    TEER procedure is performed by apposing the edges of the anterior and posterior leaflet (edge-to-edge) of MV. If the use of one MitraClip device does not result in sufficient reduction in mitral regurgitation, a second MitraClip device may be used to reduce MR optimizing the procedure.

    Treatment: Trancatheter Edge to Edge Repair

  • Mitral Valve Replacement

    Mitral-valve replacement includes complete preservation of the subvalvular apparatus to avoid dilation of the left ventricle over time. The technique of preservation, type of prosthetic valve implanted, and technique of suture placement has been chosen according to the preference of the surgeons. In SMR due to ischemic cardiomyopathy, CABG operation(Revascularization) is required

  • Restrictive Mitral Annuloplasty

    RMA may be performed with the use of complete rigid or semi-rigid annuloplasty ring which has been downsized for the annulus diameter. Since patients who received RMA have coronary artery lesions, a CABG operation is useful to ensure favorable remodeling of the left ventricle.

    Treatment: Restrictive Mitral Annuloplastie

  • Restrictive Mitral Annuloplastie Plus Subvalvular Repair

    RMA may be associated with the use of a subvalvular repair (SVR). The SVR permits the approximation or the relocation of papillary muscles which is displaced by post infarction scar formation. In patients who received SVR due to ischemic cardiomyopathy CABG operation is required

    Treatment: Restrictive Mitral Annuloplastie/Subvalvular Repair

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transcatheter Edge to Edge Mitral Valve Repair Versus Standard Surgical Mitral Valve Operation for Secondadry Mitral Regurgitation
Criteria questions
Built from NCT05090540, who can take part
Publications
Record updated
19 May 2026